Evidence that interspecies polymorphism in the human and rat cholecystokinin receptor-2 affects structure of the binding site for the endogenous agonist cholecystokinin

Journal of Biological Chemistry

Volumn 280, Issue 23, 2005, Pages 22198-22204

  Langer, Ingrid ^a,c   Tikhonova, Irina G ^a   Travers, Marie Agnès ^a   Archer Lahlou, Elodie ^a   Escrieut, Chantal ^a   Maigret, Bernard ^b   Fourmy, Daniel ^a,d  

^a CHU RANGUEIL   (France)

^b UNIVERSITÉ DE LORRAINE   (France)

^c UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^d Institut Louis Bugnard   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION ENERGY; AMINO ACIDS; CHELATION; GENETIC ENGINEERING; MOLECULAR STRUCTURE; MUTAGENESIS; NEUROLOGY;

ANTAGONISTS; GASTRIN; LIGANDS; NEUROPEPTIDES; POLYMORPHISM;

BIODIVERSITY;

CHOLECYSTOKININ; CHOLECYSTOKININ B RECEPTOR; INOSITOL PHOSPHATE; LIGAND;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; BIOLOGICAL ACTIVITY; CONTROLLED STUDY; GENETIC POLYMORPHISM; GENETIC TRANSFECTION; HORMONE RECEPTOR INTERACTION; MOLECULAR MODEL; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN STRUCTURE; RECEPTOR UPREGULATION; SEQUENCE HOMOLOGY; SITE DIRECTED MUTAGENESIS; SPECIES COMPARISON;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; COS CELLS; DNA, COMPLEMENTARY; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INOSITOL PHOSPHATES; KINETICS; LIGANDS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; MUTATION; NEURONS; PEPTIDES; POLYMORPHISM, GENETIC; PROTEIN BINDING; PROTEIN CONFORMATION; RATS; RECEPTOR, CHOLECYSTOKININ B; SPECIES SPECIFICITY; TRANSFECTION;

EID: 20444439170     PISSN: 00219258     EISSN: None     Source Type: Journal    
DOI: 10.1074/jbc.M501786200     Document Type: Article

References (31)

1. Silvente-Poirot, S., Dufresne, M., Vaysse, N., and Fourmy, D. (1993) Eur. J. Biochem. 215, 513-529
2. Noble, F., Wank, S. A., Crawley, J. N., Bradwejn, J., Seroogy, K. B., Hamon, M., and Roques, B. P. (1999) Pharmacol. Rev. 51, 745-781
3. de Weerth, A., Pisegna, J. R., Huppi, K, and Wank, S. A. (1993) Biochem. Biophys. Res. Commun. 194, 811-818
4. Wank, S. A., Pisegna, J. E., and de Weerth, A. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 8691-8695
5. Lee, Y. M., Beinborn, M., McBride, E. W., Lu, M., Kolakowski, L. F., Jr., and Kopin, A. S. (1993) J. Biol. Chem. 268, 8164-8169
6. Herranz, R. (2003) Med. Res. Rev. 23, 559-605
7. Kopin, A. S., McBride, E. W., Schaffer, K., and Beinborn, M. (2000) Trends Pharmacol. Sci. 21, 346-353
8. Beinborn, M., Lee, Y. M., McBride, E. W., Quinn, S. M., and Kopin, A. S. (1993) Nature 362, 348-350
9. Kopin, A. S., McBride, E. W., Gordon, M. C., Quinn, S. M., and Beinborn, M. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 11043-11048
10. Silvente-Poirot, S., Escrieut, C., Gales, C., Fehrentz, J. A., Escherich, A., Wank, S. A., Martinez, J., Moroder, L., Maigret, B., Bouisson, M., Vaysse, N., and Fourmy, D. (1999) J. Biol. Chem. 274, 23191-23197
11. Gales, C., Poirot, M., Taillefer, J., Maigret, B., Martinez, J., Moroder, L., Escrieut, C., Pradayrol, L., Fourmy, D., and Silvente-Poirot, S. (2003) Mol. Pharmacol. 63, 973-982
12. Silvente-Poirot, S., Escrieut, C., and Wank, S. A. (1998) Mol. Pharmacol. 54, 364-371
13. Moroder, L., Wilschowitz, L., Gemeiner, M., Gohring, W., Knof, S., Scharf, R., Thamm, P., Gardner, J. D., Solomon, T. E., and Wunsch, E. (1981) Hoppe-Seyler's Z. Physiol. Chem. 362, 929-942
14. Fourmy, D., Lopez, P., Poirot, S., Jimenez, J., Dufresne, M., Moroder, L., Powers, S. P., and Vaysse, N. (1989) Eur. J. Biochem. 185, 397-403
15. Gigoux, V., Escrieut, C., Fehrentz, J. A., Poirot, S., Maigret, B., Moroder, L., Gully, D., Martinez, J., Vaysse, N., and Fourmy, D. (1999) J. Biol. Chem. 274, 20457-20464
16. Fong, T. M., Yu, H., and Strader, C. D. (1992) J. Biol. Chem. 267, 25668-25671
17. Cascieri, M. A., Huang, R. R., Fong, T. M., Cheung, A. H., Sadowski, S., Ber, E., and Strader, C. D. (1992) Mol. Pharmacol. 41, 1096-1099
18. Oksenberg, D., Marsters, S. A., O'Dowd, B. F., Jin, H., Havlik, S., Peroutka, S. J., and Ashkenazi, A. (1992) Nature 360, 161-163
19. Kopin, A. S., McBride, E. W., Quinn, S. M., Kolakowski, L. F., Jr., and Beinborn, M. (1995) J. Biol. Chem. 270, 5019-5023
20. Anders, J., Bluggel, M., Meyer, H. E., Kuhne, R., ter Laak, A. M., Kojro, E., and Fahrenholz, F. (1999) Biochemistry 38, 6043-6055
21. Jagerschmidt, A., Guillaume-Rousselet, N., Vikland, M. L., Goudreau, N., Maigret, B., and Roques, B. P. (1996) Eur. J. Pharmacol. 296, 97-106
22. Gigoux, V., Escrieut, C., Silvente-Poirot, S., Maigret, B., Gouilleux, L., Fehrentz, J. A., Gully, D., Moroder, L., Vaysse, N., and Fourmy, D. (1998) J. Biol Chem. 273, 14380-14386
23. Gigoux, V., Maigret, B., Escrieut, C., Silvente-Poirot, S., Bouisson, M., Fehrentz, J. A., Moroder, L., Gully, D., Martinez, J., Vaysse, N., and Fourmy, A. D. (1999) Protein Sci. 8, 2347-2354
24. Escrieut, C., Gigoux, V., Archer, E., Verrier, S., Maigret, B., Behrendt, R., Moroder, L., Bignon, E., Silvente-Poirot, S., Pradayrol, L., and Fourmy, D. (2002) J. Biol. Chem. 277, 7546-7555
25. Viguera, A. R., and Serrano, L. (1995) Biochemistry 34, 8771-8779
26. Blaker, M., Ren, Y., Gordon, M. C., Hsu, J. E., Beinborn, M., and Kopin, A. S. (1998) Mol. Pharmacol. 54, 857-863
27. Jagerschmidt, A., Guillaume, N., Roques, B. P., and Noble, F. (1998) Mol. Pharmacol. 53, 878-885
28. Pommier, B., Marie-Claire, C., Da Nascimento, S., Wang, H. L., Roques, B. P., and Noble, F. (2003) J. Neurochem. 85, 454-461
29. Giragossian, C., and Mierke, D. F. (2002) Biochemistry 41, 4560-4566
30. Kopin, A. S., McBride, E. W., Chen, C., Freidinger, R. M., Chen, D., Zhao, C. M., and Beinborn, M. (2003) Proc. Natl. Acad. Sci. U. S. A. 100, 5525-5530
31. Archer-Lahlou, E., Escrieut, C., Clerc, P., Martinez, J., Moroder, L., Logsdon, C., Kopin, A., Seva, C., Dufresne, M., Pradayrol, L., Maigret, B., and Fourmy, D. (2005) J. Biol. Chem. 280, 10664-10674